Portfolio company
BMTfemme
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops rapid antigen diagnostic tests and breast screening technology for healthcare providers and individual consumers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
MammoCheck
This company develops a thermal camera and mobile application that uses artificial intelligence to provide at-home breast cancer screening for women.
Sakura MedTech
This company develops a tampon-shaped imaging device for cervical cancer screening to replace the traditional speculum for clinicians and their patients.
Elaitra
The company develops an artificial intelligence platform to assist radiologists in the early detection and diagnosis of breast cancer.
Endogene.Bio
This company develops a biological data platform using menstrual blood to provide diagnostics and patient stratification tools for pharmaceutical firms and healthcare providers.
Digistain
This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.
Teal Health
This company develops at-home cervical cancer screening devices and telehealth services for women, health systems, and employers.
Testmate Health
This company develops rapid urine-based diagnostic kits for individuals to test for sexually transmitted infections at home without requiring laboratory processing.
Reme-D
This company develops molecular diagnostic kits for human and animal diseases to support healthcare providers and researchers in underserved regions.
